google-site-verification: googlec7193c3de77668c9.html

After allogeneic transplant, VIC-1911 regimen shows low severe GVHD and no relapse

[
Results of a Phase I clinical trial show that patients who undergo a blood stem cell transplant involving a donor have a lower risk of relapse and lower rates of graft-versus-host disease when they receive the targeted therapy VIC-1911 along with the standard-of-care regimen that includes post-transplant cyclophosphamide and sirolimus.


Source link

Advertisements
Views: 4

See also  AI-aided 'master key' vaccine may block entire virus families, not single strains

Check Also

Fasting primes gut microbiome to improve intestinal recovery after radiation treatment

[ Credit: Pixabay/CC0 Public Domain A new preclinical study from the University of Texas MD …

Anticancer 'nanoswitch' technology shows promise in animal model of triple-negative breast cancer, colorectal cancer

[ A research team led by Professor Yoosoo Yang (Department of Integrative Biotechnology) of Sungkyunkwan …

Heat exhaustion or heatstroke: Can you tell the difference?

During hot weather, it can be easy to overheat, sometimes resulting in heat exhaustion or …

Leave a Reply

Available for Amazon Prime